Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
-Issues Related to Product Safety and Quality Assurance (No Bill) -Issues related to Labeling of Menstrual Products -PACK Act (Packaging and Claims Knowledge Act) HR 6832
Safer Choice Program Authorization Act of 2026
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Implementation of Cybersecurity Reporting Law -Issues related to Toxic Substances Control Act Reform -Safer Choice Program Authorization Act (S. 4664)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2026 · second_quarter · Q2
-Issues Related to Product Safety and Quality Assurance (No Bill) -Issues related to Labeling of Menstrual Products -PACK Act (Packaging and Claims Knowledge Act) HR 6832
-Implementation of Cybersecurity Reporting Law -Issues related to Toxic Substances Control Act Reform -Safer Choice Program Authorization Act (S. 4664)
Filing targets: Consumer Product Safety Commission (CPSC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
-Issues related to over the counter drug policy -Issues related to ingredient labeling -H.R. 3749(IH) Health and Endocrine Research on Personal Care Products for Women Act* -H.R.4273 To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes
Over-the-Counter Monograph Drug User Fee Amendments
Client: THE PROCTER AND GAMBLE COMPANY · Firm: THE PROCTER AND GAMBLE COMPANY
-Issues related to over the counter drug policy -Issues related to ingredient labeling -H.R. 3749(IH) Health and Endocrine Research on Personal Care Products for Women Act* -H.R.4273 To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes
-H.R.471: The SHIP IT Act -Issues related to sustainability innovations in the transportation sector (no bill) -Issues related to intermodal transportation and supply chain challenges (no bill)
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2026 · first_quarter · Q1
-Issues related to updating the Toxic Substances Control Act (No Bill) -Implementation of Cybersecurity Reporting Law
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2025 · fourth_quarter · Q4
- Issues Related to Product Safety and Quality Assurance (No Bill) - FDA Menstrual Products Guidance
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2025 · third_quarter · Q3
-Issues related to Toxic Substances Control Act reform (No Bill)
-Issues related to plastics recycling (No Bill)
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2025 · second_quarter · Q2
-Issues related to IEEPA Tariffs -Issues related to the Pharmaceuticals Section 232 Trade Investigation -Issues related to Lumber Section 232 Trade Investigation
-Issues related to over the counter drug policy -Issues related to ingredient labeling -H.R. 3749(IH) Health and Endocrine Research on Personal Care Products for Women Act* -H.R.4273 To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes
-Issues related to new chemical approvals (no bill)
Filing targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2025 · first_quarter · Q1
-Issues related to new chemical approvals (no bill) -Implementation of Cybersecurity Reporting Law
Filing targets: Consumer Product Safety Commission (CPSC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2024 · fourth_quarter · Q4
-US Corporate and International Tax Reform (no bill) -OECD Digital Tax Project (Global Minimum Tax Implementation) -OECD Digital Tax Project (Pillar One) -Taxation of Health Benefit Plans (No Bill)
Filing targets: Consumer Product Safety Commission (CPSC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2024 · second_quarter · Q2
-Issues related to new chemical approvals (no bill) -Implementation of Cybersecurity Reporting Law
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2024 · first_quarter · Q1
-Issues related to new chemical approvals (no bill)
-401(h) Surplus Proposal -OECD Digital Tax Project (Global Minimum Tax Implementation) -US Corporate and International Tax Reform (no bill) -OECD Digital Tax Project (Pillar One) -Taxation of Health Benefit Plans (No Bill) -Taxation of Digital Advertising (No Bill)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
THE PROCTER AND GAMBLE COMPANY via THE PROCTER AND GAMBLE COMPANY
2023 · fourth_quarter · Q4
-US Corporate and International Tax Reform (no bill) -OECD Digital Tax Project (Global Minimum Tax Implementation) -OECD Digital Tax Project (Pillar One) -Taxation of Health Benefit Plans (no bill) -US Tax Treaty Negotiations -Taxation of Health Benefit Plans (no Bill)
-H.R.471: The SHIP IT Act -Issues related to sustainability innovations in the transportation sector (no bill) -Issues related to intermodal transportation and supply chain challenges (no bill)
-General manufacturing and supply chain issues (no bill) -Issues related to Product Pricing and Supply Chains
Filing targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of